Medical Records Investigation of Whether Perioperative Dexmedetomidine Will Reduce the Duration of Mechanical Ventilation or Hospital Length of Stay in Patients Undergoing Minimally Invasive Cardiac Surgery

Far Eastern Memorial Hospital

Status: Completed

Conditions: Hospital Length of Stay; Minimally Invasive Cardiac Surgery; Mechanical Ventilation

Treatments: Drug: Dexmedetomidine

Study type: Observational

Funder types: Other

Identifiers

NCT05038111

110006-F

Details and patient eligibility

About

The concept of enhanced recovery after surgery (ERAS) is utilizing in multiple specialties widely. Early tracheal extubation is one of the components of ERAS that enhances postoperative recovery and reduces the length of stay in intensive care unit (ICU).Dexmedetomidine is a highly selective, shorter-acting α2-adrenergic receptor agonist that has both analgesic and sedativeeffects.It was associated with decreased mortality, time to extubation, and hospital length of stay in cardiac surgical patients according to previous studies.The purpose of this study was to investigate the effect of perioperative dexmedetomidine on patients undergoing minimally invasive cardiac surgery(MICS) who were early extubated after surgery.

Enrollment: 81 patients

Sex: All

Ages: 20 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergone minimal invasive off-pump coronary artery bypass graft (CABG), valvular surgery or combined procedures at Far Eastern Memorial Hospital, New Taipei City, Taiwan between January 1, 2020 and August 31, 2020.
• Age above 20 y/o

Exclusion criteria

• Emergency surgery
• Postoperative mechanical ventilation more than 6 hours
• Extubated in the operating room

Trial design

81 participants in 2 patient groups

Dex

Description:

Dexmedetomidine infusion during the perioperative period

Treatment:

Drug: Dexmedetomidine

Non-Dex

Description:

Did not have dexmedetomidine infusion during the perioperative period